2003

Nov 9, 2003
Guidant Receives Exclusive Expanded Indication for Heart Failure Treatment

MADIT II patients with heart failure now eligible for Cardiac Resynchronization Therapy Defibrillator Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the...

Nov 9, 2003
Guidant Announces Exclusive Sponsorship of MADIT-CRT Clinical Trial

Guidant''s Leadership in Heart Failure Therapy Continues with Landmark Study Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Nov 7, 2003
Guidant Announces Live Webcast of its Annual Investor/Analyst Conference

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will conduct a live webcast of its annual...

Oct 22, 2003
Guidant Announces U.S. Launch of Implantable Defibrillator Offering Optimal Combination of Size and Longevity

Latest Defibrillator Expands Successful Product Portfolio Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Oct 21, 2003
Guidant Announces Fourth Quarter Dividend

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s board of directors declared a fourth...

Show 5102550100 per page
Top